These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21326240)

  • 1. Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells.
    Comamala M; Pinard M; Thériault C; Matte I; Albert A; Boivin M; Beaudin J; Piché A; Rancourt C
    Br J Cancer; 2011 Mar; 104(6):989-99. PubMed ID: 21326240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis.
    Thériault C; Pinard M; Comamala M; Migneault M; Beaudin J; Matte I; Boivin M; Piché A; Rancourt C
    Gynecol Oncol; 2011 Jun; 121(3):434-43. PubMed ID: 21421261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression.
    Matte I; Lane D; Boivin M; Rancourt C; Piché A
    BMC Cancer; 2014 Apr; 14():234. PubMed ID: 24690311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis.
    Boivin M; Lane D; Piché A; Rancourt C
    Gynecol Oncol; 2009 Dec; 115(3):407-13. PubMed ID: 19747716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA125/MUC16 interacts with Src family kinases, and over-expression of its C-terminal fragment in human epithelial cancer cells reduces cell-cell adhesion.
    Akita K; Tanaka M; Tanida S; Mori Y; Toda M; Nakada H
    Eur J Cell Biol; 2013; 92(8-9):257-63. PubMed ID: 24246580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway.
    Matte I; Garde-Granger P; Bessette P; Piché A
    BMC Cancer; 2019 Apr; 19(1):406. PubMed ID: 31039761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional control of the MUC16 promoter facilitates follicle-stimulating hormone peptide-conjugated shRNA nanoparticle-mediated inhibition of ovarian carcinoma in vivo.
    Zhang MX; Hong SS; Cai QQ; Zhang M; Chen J; Zhang XY; Xu CJ
    Drug Deliv; 2018 Nov; 25(1):797-806. PubMed ID: 29542355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion.
    Rao TD; Tian H; Ma X; Yan X; Thapi S; Schultz N; Rosales N; Monette S; Wang A; Hyman DM; Levine DA; Solit D; Spriggs DR
    PLoS One; 2015; 10(5):e0126633. PubMed ID: 25965947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.
    Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J
    Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells.
    Cowden Dahl KD; Symowicz J; Ning Y; Gutierrez E; Fishman DA; Adley BP; Stack MS; Hudson LG
    Cancer Res; 2008 Jun; 68(12):4606-13. PubMed ID: 18559505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas.
    Colomiere M; Ward AC; Riley C; Trenerry MK; Cameron-Smith D; Findlay J; Ackland L; Ahmed N
    Br J Cancer; 2009 Jan; 100(1):134-44. PubMed ID: 19088723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse.
    Wang Y; Cheon DJ; Lu Z; Cunningham SL; Chen CM; Luo RZ; Xing D; Orsulic S; Bast RC; Behringer RR
    Differentiation; 2008 Dec; 76(10):1081-92. PubMed ID: 18637025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway.
    Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S
    Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
    Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
    Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of a novel microscopic technique for quantifying CA125 binding to circulating mononuclear cells in longitudinal specimens during treatment for ovarian cancer.
    Lakatos K; González G; Hoballah J; Brooker J; Jeong S; Evans C; Krauledat P; Hansen WP; Elias KM; Patankar M; Fülöp V; Konstantinopoulos PA; Cramer DW
    J Ovarian Res; 2022 Feb; 15(1):28. PubMed ID: 35219339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving role of MUC16 (CA125) in the transformation of ovarian cells and the progression of neoplasia.
    Giamougiannis P; Martin-Hirsch PL; Martin FL
    Carcinogenesis; 2021 Apr; 42(3):327-343. PubMed ID: 33608706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC16 impacts tumor proliferation and migration through cytoplasmic translocation of P120-catenin in epithelial ovarian cancer cells: an original research.
    Chen X; Li X; Wang X; Zhu Q; Wu X; Wang X
    BMC Cancer; 2019 Feb; 19(1):171. PubMed ID: 30795761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer.
    Aithal A; Junker WM; Kshirsagar P; Das S; Kaur S; Orzechowski C; Gautam SK; Jahan R; Sheinin YM; Lakshmanan I; Ponnusamy MP; Batra SK; Jain M
    PLoS One; 2018; 13(4):e0193907. PubMed ID: 29708979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch and TGFβ form a positive regulatory loop and regulate EMT in epithelial ovarian cancer cells.
    Zhou J; Jain S; Azad AK; Xu X; Yu HC; Xu Z; Godbout R; Fu Y
    Cell Signal; 2016 Aug; 28(8):838-49. PubMed ID: 27075926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR5/7-mediated PI3K activation triggers epithelial-mesenchymal transition of ovarian cancer cells through WAVE3-dependent mesothelin or OCT4/SOX2 expression.
    Park GB; Kim D
    Oncol Rep; 2017 Nov; 38(5):3167-3176. PubMed ID: 28901470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.